Disc Medicine, Inc. (IRON)
67.13
+0.10
(+0.15%)
USD |
NASDAQ |
May 21, 16:00
67.00
-0.13
(-0.19%)
After-Hours: 19:59
Disc Medicine Research and Development Expense (TTM) : 188.43M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Cytokinetics, Inc. | 400.51M |
| Regeneron Pharmaceuticals, Inc. | 5.526B |
| REGENXBIO, Inc. | 217.03M |
| Replimune Group, Inc. | 222.70M |
| Olema Pharmaceuticals, Inc. | 176.30M |